These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 5600800)
1. [Structure and effect of cardiac glycosides from the clinical viewpoint]. Sundermann A; Fiehring H Dtsch Gesundheitsw; 1967 May; 22(20):919-23. PubMed ID: 5600800 [No Abstract] [Full Text] [Related]
2. [Cardiac glycosides: their pharmacology and clinical pharmacology]. Greeff K Med Monatsschr Pharm; 1984 Feb; 7(2):37-49. PubMed ID: 6321928 [No Abstract] [Full Text] [Related]
3. [The significance of phase analysis in the pharmacotherapeutic control of the effect of cardiac glycosides]. Belostochnaia NG Ter Arkh; 1967 Apr; 39(4):65-7. PubMed ID: 5610908 [No Abstract] [Full Text] [Related]
4. [Cardiac glycosides]. Pankratov AB Med Sestra; 1978 Mar; 37(3):34-40. PubMed ID: 247167 [No Abstract] [Full Text] [Related]
5. [Experience in the use of cardiac glycosides in children with heart diseases]. Landa NM; Shcherbatova EI Vopr Okhr Materin Det; 1971 Jun; 16(6):69-73. PubMed ID: 5112039 [No Abstract] [Full Text] [Related]
6. [Are cardiac glycosides recommended following an attack of encephalomalacia?]. Aschenbrenner R Dtsch Med Wochenschr; 1968 Jan; 93(1):48. PubMed ID: 5635032 [No Abstract] [Full Text] [Related]
7. [Rational use of cardiac glycosides in certain diseases in childhood]. Sidel'nikov VM; Afanas'ev EN; Liutkevich VF Pediatr Akus Ginekol; 1975; (3):3-6. PubMed ID: 1230764 [No Abstract] [Full Text] [Related]
8. [Clinical tests of a new cardiac glycoside]. Wiontzek H; Eilmes G; Gaedt R; Haack U Ther Ggw; 1972 Jan; 111(1):46-51. PubMed ID: 4554143 [No Abstract] [Full Text] [Related]
11. [Clinical experience with a new cardiac glycoside]. Büsscher K Z Allgemeinmed; 1969 Feb; 45(6):265-8. PubMed ID: 5801646 [No Abstract] [Full Text] [Related]
12. [Values of calcium electrolytes in patients treated with cardiac glycosides]. Surbat L Med Pregl; 1975; 28(5-6):217-9. PubMed ID: 1160831 [No Abstract] [Full Text] [Related]
13. [Recent aspects of therapy with cardiac glycosides]. Bayer O; Jost F Dtsch Med J; 1970 May; 21(10):675-6 passim. PubMed ID: 5523167 [No Abstract] [Full Text] [Related]
14. [Clinical experimentation of a new tonicardiac agent: proscillaridine A]. Warembourg H; Carre A Lille Med; 1970 Mar; 15(3 Suppl 2):447-51. PubMed ID: 5421806 [No Abstract] [Full Text] [Related]
15. [Selection of cardiac glycosides for acute usage]. Beermann B; Lundman T Lakartidningen; 1974 Mar; 71(10):919. PubMed ID: 4826126 [No Abstract] [Full Text] [Related]
16. [Clinical observations on a new cardiotonic drug (Talusin)]. Amoroso A; Ghiara F Minerva Med; 1966 Oct; 57(81):3301-4. PubMed ID: 5955198 [No Abstract] [Full Text] [Related]
17. [Clinical notes on the effect of a new cardiokinetic drug (proscillaridin A)]. Muzio L Minerva Med; 1966 May; 57(43 Suppl):2005-6. PubMed ID: 5944828 [No Abstract] [Full Text] [Related]
19. [A year of clinical experience with a new cardio-active glycoside, proscillaridin]. Pezzo G; Barbera G Clin Ter; 1967 May; 41(4):357-61. PubMed ID: 5614305 [No Abstract] [Full Text] [Related]
20. [Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides]. Luise A Minerva Med; 1967 Dec; 58(96):4286-9. PubMed ID: 6083290 [No Abstract] [Full Text] [Related] [Next] [New Search]